The London Biotechnology Show 2025 exhibition floor was a vibrant epicentre of innovation, featuring nearly 100 exhibiting companies representing the entire biotechnology value chain—from laboratory equipment and health tech to compliance and logistics.
Leaders such as Thermo Fisher Scientific, Merck, Symbiotica Therapeutics, Discovery Park, and Haier Biomedical UK showcased next-gen technologies and platforms. The dedicated Startup & Innovation Zone was buzzing, with emerging companies like GutSee Health and Apeikon Therapeutics displaying novel diagnostics, delivery systems, and smart therapeutic tools.
In parallel, the two-day conference engaged renowned speakers across five content-rich tracks. Highlights included:
- A keynote from Mr. Chris Johnson on cybersecurity and innovation
- A panel on AI/ML in diagnostics featuring Novo Nordisk and Microsoft
- Strategic talks on digital health, biomedical engineering, and regenerative medicine led by experts from CGT Catapult, Pfizer, NHS GCC, and more.
The BioBridge London business matchmaking programme elevated engagement further, hosting 140+ focused meetings between buyers and solution providers including AstraZeneca, Quell Therapeutics, and LifeArc. This initiative translated networking into meaningful business outcomes, helping companies explore partnerships aligned to specific business objectives.
The show also featured the Discovery Park Startup Showcase, a high-energy platform where biotech entrepreneurs pitched ideas, engaged with investors, and gained feedback in live Dragon’s Den–style sessions. Fireside chats on what makes a founder successful brought valuable insights for both budding and seasoned innovators.
The combination of live product demos, commercial matchmaking, and thought-leadership panels made the exhibition floor the true heartbeat of London Biotechnology Show 2025.
